- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
Patent holdings for IPC class A61P 13/12
Total number of patents in this class: 5228
10-year publication summary
|
176
|
190
|
177
|
336
|
380
|
427
|
559
|
529
|
484
|
158
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1829 |
98 |
| Amicus Therapeutics, Inc. | 341 |
57 |
| Takeda Pharmaceutical Company Limited | 2961 |
51 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
40 |
| Novartis AG | 11238 |
37 |
| Bayer Pharma AG | 1096 |
37 |
| Boehringer Ingelheim International GmbH | 4629 |
35 |
| Osaka University | 3143 |
34 |
| Astellas Pharma Inc. | 1145 |
33 |
| F. Hoffmann-La Roche AG | 7958 |
32 |
| Eli Lilly and Company | 3645 |
32 |
| Tohoku University | 2526 |
30 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
29 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
27 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
27 |
| Nippon Shinyaku Co., Ltd. | 297 |
25 |
| Kyowa Hakko Kirin Co., Ltd. | 285 |
24 |
| Vertex Pharmaceuticals Incorporated | 1581 |
23 |
| The University of Tokyo | 3903 |
23 |
| Hoffmann-La Roche Inc. | 3060 |
22 |
| Other owners | 4512 |